SCHEMBL9434110

SCHEMBL9434110

CCOC(=O)C1=Nc2cc3c(c(C)c2=C1C)N=c1ccc(C#N)cc1=3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
MAPT P10636 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
CNR2 P34972 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
ELANE P08246 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 2/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434368 0.84 SMN1; SMN2 (0.36) SMN1; SMN2MAPK1NPSR1MAPTGABRA1
SCHEMBL9434910 0.83 HRH3 (0.37) SMN1; SMN2TSHRMAPK1MAPTKDM4E
SCHEMBL9434365 0.76 FGB (0.42) SMN1; SMN2TSHRMAPTKDM4EALDH1A1
SCHEMBL1388444 0.74 FGB (0.38) SMN1; SMN2TSHRMAPK1NPSR1MAPT
SCHEMBL8155848 0.72 PDE1C (0.36) SMN1; SMN2MAPTGAA
SCHEMBL9435000 0.71 MAPT (0.32) TSHRMAPTKDM4EPOLB
SCHEMBL9435019 0.69 ALDH1A1 (0.35) SMN1; SMN2NPSR1MAPTKDM4EALDH1A1
SCHEMBL8911552 0.67 SMN1; SMN2 (0.36) SMN1; SMN2NPSR1MAPTKDM4EALDH1A1
SCHEMBL8147980 0.67
SCHEMBL8797003 0.66 TSHR (0.37) SMN1; SMN2TSHRMAPK1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed